Effects of physical training on serum and pituitary growth hormone contents in diabetic rats

Pituitary

Volumn 12, Issue 4, 2009, Pages 304-308

  de Almeida Leme, José Alexandre Curiacos ^a   de Araújo, Michel Barbosa ^a   de Moura, Leandro Pereira ^a   Gomes, Ricardo José ^a   de Moura, Rodrigo Ferreira ^a   Rogatto, Gustavo Puggina ^a   de Mello, Maria Alice Rostom ^a   Luciano, Eliete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Diabetes; Growth hormone and IGF; Physical training; Pituitary

Indexed keywords

ALBUMIN; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HORMONE RESPONSE; HYPOPHYSIS; INSULIN BLOOD LEVEL; MALE; METABOLIC REGULATION; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STEADY STATE; SWIMMING; TRAINING; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 70350294673     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-009-0178-y     Document Type: Article

References (28)

1. Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S (2006) Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. J Endocrinol 188(2):263-270. doi: 10.1677/joe.1.06501
2. Gomes RJ, de Mello MA, Caetano FH, Sibuya CY, Anaruma CA, Rogatto GP, Pauli JR, Luciano E (2006) Effects of swimming training on bone mass and the GH/IGF-1 axis in diabetic rats. Growth Horm IGF Res 16(5-6):326-331. doi: 10.1016/j.ghir.2006.07.003
3. Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW Jr, Gilbert JM Jr, Berelowitz M (1990) Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: A combined defect of hypothalamic somatostatin and GH-releasing factor. Endocrinology 126(1):53-61
4. Bluet-Pajot MT, Durand D, Kordon C (1983) Influence of streptozotocin-induced diabetes on growth hormone secretion in the rat. Neuroendocrinology 36(4):307-309. doi: 10.1159/000123472
5. Shiino M, Ishibashi T (1988) Pituitary growth hormone secretory granules in streptozotocin-induced diabetic rats. Histol Histopathol 3(3):263-268
6. Park S, Peng XD, Frohman LA, Kineman RD (2005) Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice. Neuroendocrinology 81(6):360-371. doi: 10.1159/000089101
7. Catalina PF, Andrade MA, García-Mayor RV, Mallo F (2002) Altered GH elimination kinetics in type 1 diabetes mellitus can explain the elevation in circulating levels: Bicompartmental approach. J Clin Endocrinol Metab 87(4):1785-1790. doi: 10.1210/jc.87.4.1785
8. Signal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C (2004) Physical activity/exercise and type 2 diabetes. Diabetes Care 27:2518-2539. doi: 10.2337/diacare.27.10.2518
9. Leme JACA, Silveira RF, Gomes RJ, Moura RF, Sibuya CA, Mello MAR, Luciano E (2009) Long-term physical training increases liver IGF-I in normal and diabetic rats. Growth Horm IGF Res. doi: 10.1016/ j.ghir.2008.12.004
10. Gobatto CA, Sibuya CY, Kokubun E, Mello MAR (2001) Muscle glycolitic flux of malnourished, recovered and exercise trained rats. Med Sci Sports Exerc 29:5
11. Nash T (1953) The colorimetric estimation of formaldehyde by means of the hantzsch reaction. Biochem J 55:416-421
12. Henry RJ, Cannon DC, Winkelman J (1974) Clinical chemistry, principles and techniques, 2nd edn. Harper and Row Publishers Inc., New York
13. D'Ercole A, Underwood L (1986) Tissue and plasma somatomedin-C/ insulin-like growth factor-I concentrations in the human fetus during the first half of gestation. Pediatr Res 20:253-255. doi: 10.1203/ 00006450-198603000-00011
14. Lenzen S (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51:216-226. doi: 10.1007/s00125-007-0886-7
15. Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH, American Diabetes Association (2004) Physical activity/exercise and diabetes. Diabetes Care 27(1):S58-S62. doi: 10.2337/diacare.27.2007.S58
16. Eriksson J, Taimela S, Eriksson K, Parviainen S, Peltonen J, Kujala U (1997) Resistance training in the treatment of non-insulin-dependent diabetes mellitus. Int J Sports Med 18(4):242-246. doi: 10.1055/ s-2007-972627
17. Leme JA, Gomes RJ, de Mello MA, Luciano E (2007) Effects of short-term physical training on the liver IGF-I in diabetic rats. Growth Factors 25(1):9-14. doi: 10.1080/08977190701210693
18. Manetta J, Brun JF, Maimoun L, Callis A, Préfaut C, Mercier J (2002) Effect of training on the GH/IGF-I axis during exercise in middle-aged men: Relationship to glucose homeostasis. Am J Physiol Endocrinol Metab 283(5):E929-E936
19. Luciano E, Carneiro EM, Carvalho CR, Carvalheira JB, Peres SB, Reis MA, Saad MJ, Boschero AC, Velloso LA (2002) Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the phosphatidylinositol 3-kinase/Akt-1 pathway. Eur J Endocrinol 147(1):149-157. doi: 10.1530/eje.0.1470149
20. Abrass CK (1984) Diabetic proteinuria. Am J Nephrol 4:337. doi: 10.1159/ 000166849
21. O'brien T, Nguyen TT, Zimmerman BR (1998) Hyperlipidemia and diabetes mellitus. Klin Wochenschr 1:129-133. doi: 10.1007/BF01721380
22. Simsolo RB, Ong JM, Saffari B, Kern PA (1992) Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue. J Lipid Res 33:89-95
23. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton JS, Ccartney M et al (2001) Effects of the amount and intensity of exercise on plasma lipoproteins. Eur J Med 7:1483-1489
24. Hamilton MT, Areiqat DG, Hamiilton AM (2001) Bey plasma triglyceride metabolism in humans and rats during aging and physical inactivity. Int J Sport Nutr Exerc Metab 11:S97-S104
25. Carol PVl, Umpleby GS, Ward S, Imuere E, Alexander D, Dunger PH, Sönksen DL, Russell-Jones RH (1997) IGF-I administration reduces insulin requirement, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM. Diabetes 46:1453-1458. doi: 10.2337/diabetes.46.9.1453
26. Christ ER, Carroll PV, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell-Jones DL (2002) Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus. Am J Physiol Endocrinol Metab 282(5):E1154-E1162
27. Frystyk J (2004) Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 14:337-375. doi: 10.1016/j.ghir.2004.06.001
28. Busiguina S, Argente J, García-Segura LM, Chowen JA (2000) Anatomically specific changes in the expression of somatostatin, growth hormone-releasing hormone and growth hormone receptor mRNA in diabetic rats. J Neuroendocrinol 12(1):29-39. doi: 10.1046/ j.1365-2826.2000.00416.x